Molecular basis of clot retraction and its role in wound healing
- PMID: 36008192
- DOI: 10.1016/j.thromres.2022.08.010
Molecular basis of clot retraction and its role in wound healing
Abstract
Clot retraction is important for the prevention of bleeding, in the manifestations of thrombosis and for tissue repair. The molecular mechanisms behind clot formation are complex. Platelet involvement begins with adhesion at sites of vessel injury followed by platelet aggregation, thrombin generation and fibrin production. Other blood cells incorporate into a fibrin mesh that is consolidated by FXIIIa-mediated crosslinking and platelet contractile activity. The latter results in the asymmetric redistribution of erythrocytes into a tighter central mass providing the clot with stability and resistance to fibrinolysis. Integrin αIIbβ3 on platelets is the key player in these events, bridging fibrin and the platelet cytoskeleton. Glycoprotein VI participates in thrombus formation but not in the retraction. Rheological and environmental factors influence clot construction with retraction driven by the platelet cytoskeleton with actomyosin acting as the motor. Activated platelets provide procoagulant activity stimulating thrombin generation together with the release of a plethora of biologically active proteins and substances from storage pools; many form chemotactic gradients within the fibrin or the underlying matrix. Also released are newly synthesized metabolites and lipid-rich vesicles that circulate within the vasculature and mimic platelet functions. Platelets and their released elements play key roles in wound healing. This includes promoting stem cell and mesenchymal stromal cell recruitment, fibroblast and endothelial cell migration, angiogenesis and matrix formation. These properties have led to the use of autologous clots in therapies designed to accelerate tissue repair while offering the potential for genetic manipulation in both inherited and acquired diseases.
Keywords: Clot retraction; FXIII; GPVI; actomyosin; fibrin; integrin αIIbβ3; platelets; thrombin; thrombosis; wound healing.
Copyright © 2022 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Calpain cleavage of focal adhesion proteins regulates the cytoskeletal attachment of integrin alphaIIbbeta3 (platelet glycoprotein IIb/IIIa) and the cellular retraction of fibrin clots.J Biol Chem. 1997 Jan 17;272(3):1694-702. doi: 10.1074/jbc.272.3.1694. J Biol Chem. 1997. PMID: 8999848
-
The myeloperoxidase product, hypochlorous acid, reduces thrombus formation under flow and attenuates clot retraction and fibrinolysis in human blood.Free Radic Biol Med. 2019 Sep;141:426-437. doi: 10.1016/j.freeradbiomed.2019.07.003. Epub 2019 Jul 4. Free Radic Biol Med. 2019. PMID: 31279970
-
Fibrin-glycoprotein VI interaction increases platelet procoagulant activity and impacts clot structure.J Thromb Haemost. 2023 Mar;21(3):667-681. doi: 10.1016/j.jtha.2022.09.004. Epub 2022 Dec 22. J Thromb Haemost. 2023. PMID: 36696196
-
Insights into platelet-based control of coagulation.Thromb Res. 2014 May;133 Suppl 2:S139-48. doi: 10.1016/S0049-3848(14)50024-2. Thromb Res. 2014. PMID: 24862135 Review.
-
Platelets and wound healing.Front Biosci. 2008 May 1;13:3532-48. doi: 10.2741/2947. Front Biosci. 2008. PMID: 18508453 Review.
Cited by
-
A single F153Sβ3 mutation causes constitutive integrin αIIbβ3 activation in a variant form of Glanzmann thrombasthenia.Blood Adv. 2023 Jul 11;7(13):3180-3191. doi: 10.1182/bloodadvances.2022009495. Blood Adv. 2023. PMID: 36884296 Free PMC article.
-
Systemic Review of Clot Retraction Modulators.Int J Mol Sci. 2023 Jun 25;24(13):10602. doi: 10.3390/ijms241310602. Int J Mol Sci. 2023. PMID: 37445780 Free PMC article.
-
Blood clot contraction: Mechanisms, pathophysiology, and disease.Res Pract Thromb Haemost. 2022 Dec 23;7(1):100023. doi: 10.1016/j.rpth.2022.100023. eCollection 2023 Jan. Res Pract Thromb Haemost. 2022. PMID: 36760777 Free PMC article.
-
Clot Retraction and Its Correlation with the Function of Platelet Integrin αIIbβ3.Biomedicines. 2023 Aug 23;11(9):2345. doi: 10.3390/biomedicines11092345. Biomedicines. 2023. PMID: 37760786 Free PMC article.
-
A Novel Fibrin Matrix Derived from Platelet-Rich Plasma: Protocol and Characterization.Int J Mol Sci. 2024 Apr 6;25(7):4069. doi: 10.3390/ijms25074069. Int J Mol Sci. 2024. PMID: 38612879 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical